Aeon Biopharma Inc.’s stock plunged 53% in intraday trading May 3 on the company’s announcement of disappointing results from testing of its migraine drug. The Irvine-based clinical-stage company ...

By Colin Kellaher AEON Biopharma shares lost more than half of their value and hit a new all-time low after the clinical-stage biopharmaceutical ...

Digital bank AEON Bank has announced its partnership with Visa to roll out a range of payment solutions, starting with the upcoming introduction of an ...

Wrath: Aeon of Ruin is one of the most ambitious boomer shooters you'll ever come across - and one of the most punishing too.

Developers KillPixel Games and Slipgate Ironworks have released WRATH: Aeon of Ruin on consoles in partnership with the ...

Wrath: Aeon of Ruin is a retro action first-person boomer shooter developed by KillPixel Games and Slipgate Ironworks.

Wrath: Aeon of Ruin is a proper throw back to the early days of first-person shooters – so much so, it’s based on the tech that powered one of the first games I eveR played in the genre, Quake. It’s ...

Analyst Douglas Tsao of H.C. Wainwright reiterated a Buy rating on AEON Biopharma (AEON – Research Report), retaining the price target of $18.00. Douglas Tsao has given his Buy rating due to a ...

During this roadshow, customers can enjoy a range of engaging activities, along with special promotions and exclusive deals ...

Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over placebo. Despite anticipated reductions in monthly migraine days, ...

The Ministry of Energy Transition and Water Transformation (PETRA) has come up with the affordable ‘Solar BOLEH!’ initiative ...

IRVINE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum ...